Tajik, ParvinZafarmand, Mohammad HadiZwinderman, Aeilko H.Mol, Ben W.Bossuyt, Patrick M.2021-11-122021-11-122018-06-28Tajik, P, Zafarmand, M H, Zwinderman, A H, Mol, B W & Bossuyt, P M 2018, 'Development and evaluating multimarker models for guiding treatment decisions', BMC Medical Informatics and Decision Making, vol. 18, 52. https://doi.org/10.1186/s12911-018-0619-51472-6947https://hdl.handle.net/2164/17487Financial support for ProTWIN trial was provided by The Netherlands Organisation for Health Research and Development (ZonMw), the Hague, the Netherlands (grant number 200310004). Parvin Tajik is supported by an AXA Research Fund.10768159engSDG 3 - Good Health and Well-beingBiomarkerIndividualised medicineModel developmentPrediction modelsPrognosticRandomised controlled trialsStratified medicineSubgroup analysisTreatment selectionValidationR MedicineHealth PolicyHealth InformaticsRJournal article10.1186/s12911-018-0619-5http://www.scopus.com/inward/record.url?scp=85049197409&partnerID=8YFLogxK18